Our Board

Mr Tony Jones, Board Chair

Mr Jones has more than 30 years’ experience as an adviser and executive in health related businesses. He has been the managing director of Penant Capital since 2008. Penant Capital advises for profit and not for profit companies on strategy, mergers and acquisitions, partnerships/joint ventures, financing and stakeholder relations. He was previously a member of the Group Executive at Medibank Private Limited as Group Manager Strategy and Communications (2004 to 2008) and co-head of Consumer, Healthcare and Leisure investment banking at Deutsche Bank AG in Australia and New Zealand including roles on related global teams (1994-2004). Prior to this he worked as a chartered accountant with Price Waterhouse and Arthur Andersen providing audit, tax and business advisory services.


Ms Rachelle Anstey, Chief Financial Officer/Executive Director, Financial Services, Monash Health

Ms Anstey joined Monash Health in 2021 as Chief Financial Officer, with responsibility for Procurement, Logistics, Internal Audit, and Financial Services. Rachelle has a strong record of achievement and a wealth of experience across a broad range of industries and organisations, including public health. An expert in continuous improvement, Rachelle focuses on improving reporting and decision making for all levels of the organisation. Before joining Monash Health, Rachelle was Executive Director of Finance at Peninsula Health, providing critical insights and commercial guidance to support the organisation’s strategic direction. Rachelle has also worked in senior finance roles for Alfred Health, Melbourne Water and RACV, leading large teams to deliver successful financial, payroll and revenue services alongside procurement and supply programs.

Jane Bell jpg photo

Mrs Jane Bell BEc, LLB, LLM (Lond), FAICD

Mrs Bell is a banking and finance lawyer and non-executive director with more than 30 years’ experience in leading law firms, financial services, and corporate treasury operations gained living in Melbourne, London, Toronto, San Francisco and Brisbane. Mrs Bell has been a non-executive director since 2002, serving on 14 boards including 10 health and medical research boards. Mrs Bell currently serves as the Deputy Chair of Monash Health, a Director of Mesoblast Limited (ASX:MSB), (Nasdaq:MESO), Amplia Therapeutics Limited (ASX:ATX), and is a Member of the Administrative Appeals Tribunal. Mrs Bell is a former Chair of Melbourne Health (Royal Melbourne Hospital), Chair of Biomedical Research Vic, Deputy Chair of Westernport Water Corporation, Director of UCA Funds Management, WorkSafe Victoria, Hudson Institute of Medical Research-Monash Institute of Medical Research-Prince Henry’s Institute of Medical Research, Queensland Institute of Medical Research Trust, Australian Red Cross (Qld), Victorian Women’s Housing Association and Chair of the Community Advisory Group of the Melbourne Genomics Health Alliance.

Jane holds a Bachelor of Laws from The University of Melbourne, Master of Laws from Kings College, London, Bachelor of Economics from Monash University and is a Fellow of the Australian Institute of Company Directors.


Mr Stuart Donaldson

Mr Donaldson was Chief Financial Officer of Monash Health from January 2017 to November 2021. Prior to this, Stuart was the Chief Financial Officer for RMIT University for seven years; and then previously held a number of senior finance roles within the FMCG Industry, notably Chief Financial Officer for Cadbury Schweppes Australia and New Zealand. These roles have enabled Stuart to develop excellent financial acumen, combined with strategic thinking and commercial know how, to partner businesses to deliver on both the long term and short-term agenda. His experience across many facets of business include, acquisitions, divestments, negotiation of funding facilities, system implementations, implementation of reporting and purchasing systems, shared business services (on shore and off shore), strategic tax initiatives, organisational change management, implementing Integrated Business Management processes, driving improvement in key performance indicators and embedding financial business partnering. Stuart is a Fellow of the Certified Practising Accountants of Australia.


Professor Eugine Yafele, Monash Health Chief Executive

Professor Eugine Yafele commenced his role as Chief Executive of Monash Health in March 2024. Relocating from the United Kingdom to Australia to take up this position, Professor Yafele was recognised as the top National Health Service (NHS) CEO in 2022 by the Health Service Journal.

Professor Yafele was previously Chief Executive Officer at University Hospitals Bristol and Weston NHS Foundation Trust. In this role, patient and consumer experience was his priority as he led COVID recovery and restoration of services and integration of pathways and improvement across Bristol and Weston-super-Mare. In partnership with North Bristol NHS Trust, he delivered the joint clinical strategy to create world-class acute and tertiary care across Bristol, North Somerset and South Gloucestershire.

Prior to that, Professor Yafele was Chief Executive Officer at Dorset Healthcare University NHS Foundation Trust (DHC). In his first year as CEO, he led the organisation to achieve a Care Quality Commission rating of Outstanding, and, under his leadership, DHC ranked among the top four Trusts in the NHS annual staff survey for three consecutive years – performing the best nationally on staff engagement and empowerment.

Professor Yafele brings a deep and broad experience across senior clinical, operational and leadership roles to Monash Health and a particular interest in value-based healthcare and reducing health inequities.

Board Contact:

JMPH Board Secretary

Phone: (03) 9594 4919

Email: jmphexecoffice@monashhealth.org

Start typing and press Enter to search